Diabetes care in black and white veterans in the southeastern U.S

Jennifer G Twombly, Qi Long, Ming Zhu, Peter W F Wilson, K M Venkat Narayan, Lisa-Ann Fraser, Brian C Webber, Lawrence S Phillips, Jennifer G Twombly, Qi Long, Ming Zhu, Peter W F Wilson, K M Venkat Narayan, Lisa-Ann Fraser, Brian C Webber, Lawrence S Phillips

Abstract

Objective: Eliminating health disparities is a national priority, but progress has been difficult because of racial/ethnic differences in insurance coverage and access to health care. We investigated whether there were differences in diabetes care in the Veterans Administration (VA), where health care access should be relatively uniform.

Research design and methods: A1C and plasma glucose were compared before/after diagnosis of diabetes.

Results: Data were available for 1,456 black and 2,624 white veterans who met criteria for consistent primary care. Over 4-5 years before and after diagnosis, blacks had similar glucose and approximately 0.2% higher A1C levels than whites, and A1C differences could be attributed to glucose-independent associations between race and A1C. Blacks and whites also had comparable intervals between diagnostic-level hyperglycemia and diagnosis and between diagnosis and drug initiation. However, A1C was higher in blacks at the time of diagnosis (7.8 vs. 7.1%) and at initiation of pharmacotherapy (8.5 vs. 7.8%) (both P < 0.001). Differences in A1C at diagnosis and drug initiation were too large to be explained by differences in age, sex, BMI, and glucose-independent associations between race and A1C.

Conclusions: In the VA, glucose levels are generally comparable in blacks and whites except at the times of diagnosis and initiation of pharmacotherapy, when glucose levels are higher in blacks. While understanding the basis for such residual disparities may be important to improve the health of racial/ethnic minorities in the U.S., a health care system with structure and organization similar to that in the VA may also contribute importantly to relieving disparities in health.

Figures

Figure 1
Figure 1
Levels of A1C (A) and random plasma glucose (B) in black and white veterans before and after the diagnosis of diabetes. Years before and after the date of diagnosis are shown and measures averaged for each patient within 6 months before and 6 months after the date of diagnosis and each year before and after the date of diagnosis. Data are means ± SEM. Numbers of black and white veterans, respectively, contributing to data points were as follows: year −4, 126 and 244; year −3, 217 and 434; year −2, 389 and 742; year −1, 570 and 1,047; year 0, 1,258 and 2,166; year +1, 1,218 and 2,183; year +2, 1,199 and 2,198; year +3, 1,240 and 2,207; year +4, 1,063 and 1,846; year +5, 571 and 953.

References

    1. Cowie CC, Rust KF, Ford ES, Eberhardt MS, Byrd-Holt DD, Li C, Williams DE, Gregg EW, Bainbridge KE, Saydah SH, Geiss LS: Full accounting of diabetes and pre-diabetes in the U.S. population in 1988–1994 and 2005–2006. Diabetes Care 2009; 32: 287– 294
    1. Kokkinos P, Myers J, Nylen E, Panagiotakos DB, Manolis A, Pittaras A, Blackman MR, Jacob-Issac R, Faselis C, Abella J, Singh S: Exercise capacity and all-cause mortality in African American and Caucasian men with type 2 diabetes. Diabetes Care 2009; 32: 623– 628
    1. Hsu CY, Iribarren C, McCulloch CE, Darbinian J, Go AS: Risk factors for end-stage renal disease: 25-year follow-up. Arch Intern Med 2009; 169: 342– 350
    1. Gregg EW, Sorlie P, Paulose-Ram R, Gu Q, Eberhardt MS, Wolz M, Burt V, Curtin L, Engelgau M, Geiss L: the 1999–2000 National Health and Nutrition Examination Survey. Prevalence of lower-extremity disease in the U.S. adult population >40 years of age with and without diabetes: 1999–2000 National Health and Nutrition Examination survey. Diabetes Care 2004; 27: 1591– 1597
    1. Kirk JK, D'Agostino RB, Jr, Bell RA, Passmore LV, Bonds DE, Karter AJ, Narayan KM: Disparities in HbA1c levels between African-American and non-Hispanic white adults with diabetes: a meta-analysis. Diabetes Care 2006; 29: 2130– 2136
    1. Saydah S, Cowie C, Eberhardt MS, De Rekeneire N, Narayan KM: Race and ethnic differences in glycemic control among adults with diagnosed diabetes in the United States. Ethn Dis 2007; 17: 529– 535
    1. Karter AJ, Ferrara A, Liu JY, Moffet HH, Ackerson LM, Selby JV: Ethnic disparities in diabetic complications in an insured population. JAMA 2002; 287: 2519– 2527
    1. Tseng CW, Tierney EF, Gerzoff RB, Dudley RA, Waitzfelder B, Ackermann RT, Karter AJ, Piette J, Crosson JC, Ngo-Metzger Q, Chung R, Mangione CM: Race/ethnicity and economic differences in cost-related medication underuse among insured adults with diabetes: the Translating Research Into Action for Diabetes Study. Diabetes Care 2008; 31: 261– 266
    1. Rhee MK, Cook CB, Dunbar VG, Panayioto RM, Berkowitz KJ, Boyd B, George CD, Lyles RH, El-Kebbi IM, Phillips LS: Limited health care access impairs glycemic control in low income urban African Americans with type 2 diabetes. J Health Care Poor Underserved 2005; 16: 734– 746
    1. Ziemer DC, Kolm P, Foster JK, Weintraub WS, Vaccarino V, Rhee MK, Varughese RM, Tsui CW, Koch DD, Twombly JG, Narayan KM, Phillips LS: Random plasma glucose in serendipitous screening for glucose intolerance: screening for impaired glucose tolerance study 2. J Gen Intern Med 2008; 23: 528– 535
    1. International Expert Committee. International Expert Committee report on the role of the A1C assay in the diagnosis of diabetes. Diabetes Care 2009; 32: 1327– 1334
    1. Miller DR, Safford MM, Pogach LM: Who has diabetes? Best estimates of diabetes prevalence in the Department of Veterans Affairs based on computerized patient data. Diabetes Care 2004; 27( Suppl. 2): B10– B21
    1. Lewis GF, McNally C, Blackman JD, Polonsky KS, Barron WM: Prior feeding alters the response to the 50-g glucose challenge test in pregnancy: the Staub-Traugott effect revisited. Diabetes Care 1993; 16: 1551– 1556
    1. Mason CC, Hanson RL, Knowler WC: Progression to type 2 diabetes characterized by moderate then rapid glucose increases. Diabetes 2007; 56: 2054– 2061
    1. Tabak AG, Jokela M, Akbaraly TN, Brunner EJ, Kivimaki M, Witte DR: Trajectories of glycaemia, insulin sensitivity, and insulin secretion before diagnosis of type 2 diabetes: an analysis from the Whitehall II study. Lancet 2009; 373: 2215– 2221
    1. Herman WH, Dungan KM, Wolffenbuttel BH, Buse JB, Fahrbach JL, Jiang H, Martin S: Racial and ethnic differences in mean plasma glucose, hemoglobin A1c, and 1,5-anhydroglucitol in over 2000 patients with type 2 diabetes. J Clin Endocrinol Metab 2009; 94: 1689– 1694
    1. Rogers WH, Kazis LE, Miller DR, Skinner KM, Clark JA, Spiro A, 3rd, Fincke RG: Comparing the health status of VA and non-VA ambulatory patients: the veterans' health and medical outcomes studies. J Ambul Care Manage 2004; 27: 249– 262
    1. Asch SM, Kerr EA, Keesey J, Adams JL, Setodji CM, Malik S, McGlynn EA: Who is at greatest risk for receiving poor-quality health care? N Engl J Med 2006; 354: 1147– 1156
    1. Asch SM, McGlynn EA, Hogan MM, Hayward RA, Shekelle P, Rubenstein L, Keesey J, Adams J, Kerr EA: Comparison of quality of care for patients in the Veterans Health Administration and patients in a national sample. Ann Intern Med 2004; 141: 938– 945
    1. Kerr EA, Gerzoff RB, Krein SL, Selby JV, Piette JD, Curb JD, Herman WH, Marrero DG, Narayan KM, Safford MM, Thompson T, Mangione CM: Diabetes care quality in the Veterans Affairs Health Care System and commercial managed care: the TRIAD study. Ann Intern Med 2004; 141: 272– 281
    1. Pogach LM, Brietzke SA, Cowan CL, Jr, Conlin P, Walder DJ, Sawin CT: Development of evidence-based clinical practice guidelines for diabetes: the Department of Veterans Affairs/Department of Defense guidelines initiative. Diabetes Care 2004; 27( Suppl. 2): B82– B89
    1. Meduru P, Helmer D, Rajan M, Tseng CL, Pogach L, Sambamoorthi U: Chronic illness with complexity: implications for performance measurement of optimal glycemic control. J Gen Intern Med 2007; 22( Suppl. 3): 408– 418
    1. Fan T, Koro CE, Fedder DO, Bowlin SJ: Ethnic disparities and trends in glycemic control among adults with type 2 diabetes in the U.S. from 1988 to 2002. Diabetes Care 2006; 29: 1924– 1925
    1. Brown AF, Gregg EW, Stevens MR, Karter AJ, Weinberger M, Safford MM, Gary TL, Caputo DA, Waitzfelder B, Kim C, Beckles GL: Race, ethnicity, socioeconomic position, and quality of care for adults with diabetes enrolled in managed care: the Translating Research Into Action for Diabetes (TRIAD) study. Diabetes Care 2005; 28: 2864– 2870
    1. Rhee MK, Ziemer DC, Caudle J, Kolm P, Phillips LS: Use of a uniform treatment algorithm abolishes racial disparities in glycemic control. Diabetes Educ 2008; 34: 655– 663

Source: PubMed

3
Abonnieren